Search research articles
Contact Us
Filters
Showing results (181-190 of 397) with videos related to
Page
of 40
Sort By:
The New England Journal of Medicine
|
September 4, 1975
Letter: Huntington's disease: treatment with imidazole-4-acetic acid
I Shoulson, T N Chase, E Roberts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 1, 1993
Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980
D Bravi, T L Davis, M M Mouradian, et al.
European Journal of Pharmacology
|
September 24, 1982
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy
S L Cohen, M Knight, C A Tamminga, et al.
Brain Research
|
December 24, 1991
Regional cerebral glucose metabolism compared in rodents and humans
J Blin, C A Ray, T N Chase, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Pathogenetic studies of motor fluctuations in Parkinson's disease
T N Chase, M M Mouradian, G Fabbrini, et al.
Neuropharmacology
|
November 1, 1992
Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat
C A Ray, J Blin, T N Chase, et al.
Behavioral and Neural Biology
|
September 1, 1983
Minimized tolerance to the suppressive effects of CCK8 on operant responding
S L Cohen, M Knight, C A Tamminga, et al.
Synapse (New York, N.Y.)
|
May 20, 2000
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats
C Marin, A Jimenez, M Bonastre, et al.
Acta Neurologica Scandinavica
|
August 1, 1992
CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy
I Litvan, W H Berrettini, J R Atack, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1994
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
L V Metman, J Hoff, M M Mouradian, et al.
Page
of 40
Search research articles
Search
Showing results (181-190 of 397) with videos related to
Sort By:
Page
of 40
The New England Journal of Medicine
|
September 4, 1975
Letter: Huntington's disease: treatment with imidazole-4-acetic acid
I Shoulson, T N Chase, E Roberts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 1, 1993
Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980
D Bravi, T L Davis, M M Mouradian, et al.
European Journal of Pharmacology
|
September 24, 1982
Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy
S L Cohen, M Knight, C A Tamminga, et al.
Brain Research
|
December 24, 1991
Regional cerebral glucose metabolism compared in rodents and humans
J Blin, C A Ray, T N Chase, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Pathogenetic studies of motor fluctuations in Parkinson's disease
T N Chase, M M Mouradian, G Fabbrini, et al.
Neuropharmacology
|
November 1, 1992
Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat
C A Ray, J Blin, T N Chase, et al.
Behavioral and Neural Biology
|
September 1, 1983
Minimized tolerance to the suppressive effects of CCK8 on operant responding
S L Cohen, M Knight, C A Tamminga, et al.
Synapse (New York, N.Y.)
|
May 20, 2000
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats
C Marin, A Jimenez, M Bonastre, et al.
Acta Neurologica Scandinavica
|
August 1, 1992
CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy
I Litvan, W H Berrettini, J R Atack, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1994
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa
L V Metman, J Hoff, M M Mouradian, et al.
Page
of 40